Solu
Building the world's most extensive pathogen DNA library
Founded 2022
Finland
7 employees
Pre Seed
Total: $1.00M
Biotechnology
Finland
7 employees
Pre Seed
Total: $1.00M
Biotechnology
General Information
Get notified when Solu moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Discover More
Finland Market
Biotechnology
About Solu
Taxonomy: genomics, pathogen DNA, bacterial DNA analysis, epidemic prevention
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Pre Seed Round | •••••• | 3 |
|
15 Jun 2023 |
Solu Alternatives & Competitors
Solu vs
Solu vs
Bode Technology
United States
Bode provides accredited forensic DNA investigative solutions and products enabling law enforcement...
168 employees
Enterprise Software
Solu vs
Mitotyping Technologies
United States
The Clear Choice for mtDNA Analysis
2 employees
Analytics, Biotechnology
FAQ About Solu
Building the world's most extensive pathogen DNA library
Solu was founded in 2022.
Solu is headquartered in Finland.
Solu operates in the following industries: Biotechnology.
Solu has approximately 7 employees.
Solu has completed 1 funding round, raising a total of $1.00M. The latest funding stage is Pre Seed.
Top alternatives and competitors to Solu include Touchlight, Bode Technology, Mitotyping Technologies, PooPrints, Travelsify. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Solu and Touchlight are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors Solu and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
